Quantcast

Latest Organofluorides Stories

2014-04-30 23:21:01

Court documents indicate some men who filed Risperdal lawsuits involving gynecomastia allege they were forced to undergo liposuction or mastectomies to remove excess breast tissue, and suffered severe psychological and emotional distress, reports Wright & Schulte LLC. New York, NY (PRWEB) April 30, 2014 Wright & Schulte LLC, an experienced personal injury law firm representing plaintiffs in Risperdal gynecomastia lawsuits, notes that the First Judicial District Court of...

2014-04-30 08:24:10

DUBLIN, April 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/r9mnq5/global_and ) has announced the addition of the "Global and Chinese PCTFE Industry Report 2014" [http://www.researchandmarkets.com/research/r9mnq5/global_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Global and Chinese Polychlorotrifluoroethene (PCTFE) Industry Report 2014 is a professional and in-depth...

2014-04-29 16:32:08

- Zykadia (ceritinib) demonstrated an overall response rate of 54.6% in patients with ALK+ metastatic NSCLC who have no other treatment option[1] EAST HANOVER, N.J., April 29, 2014 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Zykadia(TM) (ceritinib, previously known as LDK378) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or are...

2014-04-28 16:31:49

DUBLIN, April 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration (FDA) challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex(®) (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules. Actavis maintains that the FDA improperly awarded sole exclusivity on generic Celebrex(®) to...

2014-04-26 23:01:46

A Recent Decision by The Arkansas Supreme Court Not To Reconsider Risperdal Lawsuit Judgement In A Recent Medicaid Fraud Lawsuit Has Many Concerned Columbus, OH (PRWEB) April 26, 2014 The Risperdal lawsuit lawyers at Wright & Schulte LLC are concerned with the recent decision by the Arkansas Supreme Court not to reconsider its reversal of a $1.2 billion judgement against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc., the makers of the antipsychotic drug...

2014-04-25 23:02:33

The Firm is investigating Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia due to their use of the antipsychotic medication. New York, New York (PRWEB) April 25, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) that allege the antipsychotic medication caused men and boys to develop gynecomastia, or male breast growth, continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that the Arkansas Supreme Court has rejected a...

2014-04-24 23:16:34

National network of attorneys will continue to offer complimentary consultations to consumers of all ages who may be seeking compensation over allegations of gynecomastia and other side effects. San Diego, CA (PRWEB) April 24, 2014 http://www.resource4thepeople.com/defectivedrugs/risperdal.html Resource4thePeople announced today that it is encouraged by the overwhelming response to its offer of free consultations to consumers over allegations that the antipsychotic medication Risperdal...

2014-04-24 23:00:57

The Firm is evaluating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the statin medication. New York, New York (PRWEB) April 24, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that allege the popular statin drugs caused some patients to develop Type 2 diabetes continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, District of South Carolina. According to court documents, the...

2014-04-24 08:36:01

DUBLIN, April 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Pfizer, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Celebrex(® )(celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules. Celebrex(®) is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults. Under the terms...

2014-04-23 23:17:13

A Recent Study Finds Rising Number of Children in Foster Care Are Receiving Risperdal, Other Atypical Antipsychotic Drugs to Treat ADHD Columbus, OH (PRWEB) April 23, 2014 Wright & Schulte LLC, an experienced law firm representing clients in Risperdal lawsuits, notes that a recently published study has raised concerns about the off-label use of Risperdal and other atypical antipsychotic drugs among children in foster care. According to a report from HealthDay News, the study drew data...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related